Cognitive improvement by daily intake of coffee cherry pulp extract from Coffea canephora var. Robusta in a Japanese population: A randomized, placebo-controlled, double-blind, parallel-group comparison trial
Rattachement africain : jp. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
BACKGROUND: In coffee-producing regions, coffee cherry pulp is usually discarded despite its potential bioactivity. This study examined the effects of coffee cherry pulp extract from Coffea canephora var. Robusta (CCPER) on cognitive function in healthy adults and its neurite outgrowth effect on PC12 cells. METHODS: This randomized, placebo-controlled, double-blind, parallel-group trial included 66 individuals aged ≥ 40 years with suspected mild cognitive impairment. Participants were randomized in equal groups using a computer-generated list. They were assigned to either the high-dose CCPER, low-dose CCPER (20 or 5 mg/day of dimeric B-type procyanidins (PCs) consisting of two isomers with procyanidins B1 and B3 without procyanidin B2, respectively), or placebo group, with each group receiving five capsules daily for 12 weeks (UMIN000051275). In vitro, PC12 cells were treated with either CCPER (0.1 or 0.5 µg/mL) or PCs (0.0021 or 0.0105 µg/mL) for 3 or 6 days. Neurite outgrowth was evaluated using a microscope. RESULTS: Sixty participants completed the intervention. After the 12-week intervention, the primary outcome-a standardized composite memory score on Cognitrax-was significantly higher in the high-dose group than in the placebo group (difference: 12.1, 95% confidence interval: 0.7-23.5, P = 0.038). Contrarily, no significant difference was observed in the low-dose group. No adverse events occurred. In vitro, CCPER and PCs treatments significantly promoted neurite extension compared with the control (P < 0.05). CONCLUSION: Daily intake of CCPER (20 mg/day PCs) improved cognitive function, particularly visual memory, likely due to the neurite outgrowth-promoting effects of its PCs observed in PC12 cells.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Cognitive improvement by daily intake of coffee cherry pulp extract from Coffea canephora var. Robusta in a Japanese population: A randomized, placebo-controlled, double-blind, parallel-group comparison trial
- Date Crossref
- 01/09/2026
- Éditeur
- Elsevier BV
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Orthomedico Inc. (Japan) pays non établi dans la noticeEntreprise
-
Takara (Japan) pays non établi dans la noticeEntreprise
-
Kishokai Medical Corporation pays non établi dans la noticeInstitution
-
LTD. UCC UESHIMA COFFEE CO. pays non établi dans la noticeEntreprise
-
Takara Clinic Medical Corporation Seishinkai pays non établi dans la noticeÉtablissement de santé
Orthomedico Inc. (Japan), Takara (Japan) et Kishokai Medical Corporation, avec 2 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.